Stocks waiting for the news

Watch Out

 In a notice to the Bombay Stock Exchange (BSE), KNC-6 is a novel dual action anti-uscerant having significant anti-secretory and cytoprotective properties with quick onset of action.

 The company has also filed patent application for KNC-6 in 30 other countries including Japan, Australia, Canada and the European countries.

 Lupin to discontinue the sale of share to New bridge Capital by its promoters. In a notice to the Bombay Stock Exchange, the company said that the promoters, Dr D B Gupta & Associates, have decided to discontinue negotiations in respect to the sale of 5037713 equity shares of Rs 10 each constituting 12.55 per cent of equity capital to Newbridge Capital.